Company Filing History:
Years Active: 2022
Title: Toshiro Kobori: Innovator in Biotinylated Proteins
Introduction
Toshiro Kobori is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of biotinylated proteins using genetically engineered silkworms. His innovative work has the potential to impact various applications in medicine and agriculture.
Latest Patents
Kobori holds a patent for a "Biotinylated and oxidized LDL receptor and advanced glycation end product receptor produced using genetically engineered silkworm." This invention pertains to a silkworm-type biotinylated CTLD14 or sRAGE and outlines a method for manufacturing these proteins. The method includes several steps, such as inserting a nucleic acid molecule for coding biotin ligase and protein into a silkworm, expressing these proteins, and administering biotin to obtain the biotinylated protein.
Career Highlights
Toshiro Kobori is affiliated with the National Agriculture and Food Research Organization, where he conducts his research and development activities. His work focuses on advancing the understanding and application of biotinylated proteins, which can have significant implications in various scientific fields.
Collaborations
Kobori collaborates with esteemed colleagues, including Sachiko Machida and Miyuki Kuramochi. Their combined expertise contributes to the innovative research being conducted at their organization.
Conclusion
Toshiro Kobori's contributions to the field of biotechnology through his patented inventions highlight the importance of innovation in developing new solutions. His work with biotinylated proteins showcases the potential of genetically engineered organisms in advancing scientific research and applications.